# Statespace: High-Level Overview
Statespace is a neuroscience-driven performance analytics company that combines cognitive science, artificial intelligence, and data science to help gamers and individuals with motor skill challenges improve through standardized measurement and training[2][5]. Founded in 2017, the company is best known for Aim Lab, a training simulator that replicates first-person shooter physics to quantify player skill and accelerate improvement[2][5].
The company operates across two primary markets: competitive gaming and digital health. In gaming, Statespace serves individual players and esports professionals with aim training tools, AI-powered coaching, and performance dashboards[5]. In digital health, it has partnered with institutions like Johns Hopkins University and New York University to help stroke recovery patients and individuals with cerebral palsy improve motor skills, while also supporting research on brain concussions[2]. With five million active monthly users in gaming and $113.69 million in total funding raised across multiple rounds, Statespace has demonstrated significant growth momentum[2][6].
# Origin Story
Statespace was founded in 2017 by neuroscientists from New York University, giving the company a distinctive scientific foundation from inception[4]. Rather than building another casual gaming tool, the founders applied rigorous neuroscience research to competitive gaming, creating Aim Lab as their flagship product—a training simulator built from the ground up to quantify player skill beyond traditional metrics like kill-death ratios[4][5].
Early traction came quickly. The company raised $2.5 million in August 2019, followed by a $15 million Series A in May 2020 led by Khosla Ventures[4]. This early validation attracted talent from major tech companies: Scott Raymond (formerly Facebook, Airbnb) joined as VP of Engineering, Jenna Hannon (formerly Uber) as VP of Marketing, and Phil Charm (formerly Checkr, Gainsight) as VP of Growth[4]. The company's pivot into digital health emerged organically from recognizing that its cognitive measurement technology could address rehabilitation and neurological applications—leading to grant applications and partnerships with academic medical centers[4].
# Core Differentiators
- Neuroscience-backed measurement: Unlike competitors, Statespace measures cognitive ability across multiple dimensions—visual acuity across screen quadrants, reaction time, and personality-driven play-style biases—rather than relying solely on traditional gaming metrics[4][5]
- Dual-market applicability: The same technology powers both competitive gaming training and clinical health applications, creating multiple revenue streams and reducing market risk[2][5]
- Machine learning-driven personalization: The company's unique dataset enables powerful algorithms that classify player skillsets and create personalized training regimens, with applications extending to player scouting, matchmaking, and cheat detection[5]
- Institutional partnerships: Direct relationships with esports organizations (100 Thieves, Philadelphia Fusion, Riot Games' VCT Challengers) and academic medical centers provide both credibility and distribution channels[2][4]
- Multi-platform expansion: Statespace has launched mobile versions of Aim Lab and brought the product to Xbox, with PlayStation support planned, broadening accessibility beyond PC gamers[4]
# Role in the Broader Tech Landscape
Statespace sits at the intersection of three major tech trends: the professionalization of esports, the application of neuroscience to consumer products, and the expansion of digital health solutions. The competitive gaming market has grown to exceed American football viewership, yet lacked data-driven performance measurement tools—a gap Statespace directly addresses[5].
The company's success reflects broader investor confidence in esports infrastructure and the monetization of gaming analytics. Its funding trajectory—from $2.5 million (2019) to $50 million in Series C (2024)—demonstrates sustained venture capital appetite for gaming-adjacent technologies[2][4]. Additionally, Statespace's pivot into stroke rehabilitation and neurological applications signals how gaming technology can create legitimate clinical value, potentially opening doors to healthcare reimbursement and regulatory pathways that traditional gaming companies cannot access[2].
The company influences the ecosystem by establishing that rigorous neuroscience can underpin consumer gaming products, potentially inspiring similar approaches across fitness, education, and other performance-training verticals.
# Quick Take & Future Outlook
Statespace is positioned for continued expansion across both gaming and healthcare verticals. The company's stated plans include expanding training tools, coaching programs, and digital health initiatives[2]. Key growth drivers include scaling its five million monthly active user base, deepening institutional partnerships with esports organizations, and advancing clinical applications that could unlock healthcare funding and regulatory approval.
The primary question ahead is whether Statespace can successfully monetize its dual-market strategy without diluting focus. Gaming offers immediate revenue through subscriptions and team licensing, while healthcare offers larger TAM but longer sales cycles and regulatory complexity. How the company balances these paths—and whether it can achieve profitability while maintaining innovation—will define its trajectory. The recent rebranding to "Aimlabs" suggests a potential strategic shift toward emphasizing the product over the corporate entity, signaling confidence in market positioning[6].
